Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal CarcinomaSaidu Kamara(Wenzhou Medical University), Lifang Zhang(Ningbo University)CellsNovember 5, 202410.3390/cells13221823Cited by 0SaveCiteExport RISWatch citationsRelated PapersGeneration of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells|Cell Death and Disease|2020|28